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Available online 22 June 2007Abstract—Novel spiroborate esters derived nonracemic 1,2-aminoalcohols and ethylene glycol are reported as highly eﬀective cat-
alysts for the asymmetric borane reduction of a variety of prochiral ketones with borane–dimethyl sulﬁde complex at room temper-
ature. Optically active alcohols were obtained in excellent chemical yields using 0.1–10 mol % of catalysts with up to 99% ee.
 2007 Elsevier Ltd. Open access under CC BY-NC-ND license.N
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OHThe asymmetric synthesis of secondary enantiopure
alcohols from prochiral ketones is a key step in the prep-
aration of a variety of pharmaceutical products.1,2 To
accomplish this transformation with high enantioselec-
tivity, new methods, such as, asymmetric transfer hydro-
genation,3 metal catalyzed hydrogenations,4 enzymatic
reactions5 and novel metal hydride reagents,6–9 are con-
tinuously being developed as valuable synthetic tools.
Chiral boron reagents, in particular oxazaborolidines7
derived from nonracemic 1,2-aminoalcohols, are well
known catalysts for the synthesis of highly enantiopure
secondary alcohols. Other oxazaborolidine-like
compounds have been applied for the borane reduction
of prochiral ketones with good to excellent
enantioselectivities.8,9
Borates and boronates have been previously established
as eﬀective chirality transfer reagents.10 Borates accessed
from nonracemic 1,1 0-bi-2-naphtyldiol and complexed
to anilines reduce acetophenone with up to 64% ee.11
Spiroborate esters prepared from nonracemic 1,1 0-bi-2-
naphtylborate esters and enantiopure 1,2-aminoalcohols
(or 2-aminoacids) have been found to catalytically
reduce prochiral aromatic and aliphatic ketones with
modest to high enantioselectivities.8b,c0040-4039  2007 Elsevier Ltd.
doi:10.1016/j.tetlet.2007.06.086
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Open access under CC BY-NC-ND license.We recently reported the synthesis of a new class of crys-
talline, air- and moisture stable spiroborate esters that
were examined for the reduction of acetophenone as a
model substrate to obtain nonracemic 1-phenyletha-
nol.12 Catalysts 1–3 (Scheme 1) proved to be the most
valuable due to their outstanding enantioselectivity, fac-
ile synthesis, purity and convenience of handling. We
present here the X-ray crystal structure of catalyst 1, a
correlation study of the catalytic load of 1 with the
enantio-purity of alcohol, and the asymmetric borane
reduction of representative ketones using 1–3 as
catalyst.
Spiroborate esters 1 and 2 are readily prepared from
commercially available diphenyl valinol and diphenyl-R1 R2
O
0.1 equiv. Cat.1-3/THF
BH3-DMS/ 25 oC
R1 R2
*
Scheme 1.
Figure 1. Crystal structure of spiroborate 1.
Table 1. Electronic and steric eﬀects on asymmetric reduction of
aromatic and aliphatic ketones using spiroborates
Entry Substrate Cat.a Yieldb (%) eec (%)
1 O 1 98 99
d (R)
2 2 97 98d (R)
3 3 96d (R)
4
O
MeO
1 90 92e (R)
5 2 94 97 (R)
6
O
1 96 96 (R)
7
O
1 99 >99 (R)
8
O
MeO
1 81 98e (R)
9
O
1 84 99f (R)
10
O
1 94 87
11
O
1 90 72 (R)
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dure.13 1,1,2-Triphenyl ethanolamine was synthesized
by established methods.14 The white crystalline spirobo-
rate complex 1 was found to be particularly stable after
being exposed to moist air for 24 h at 25 C, as evi-
denced by its unchanged 11B, 1H and 13C NMR spectra.
The X-ray diﬀraction analysis of 1 presented in Figure 1
clearly shows the structure of the amino spiroborate
complex.15 The observed B1–N1 bond distance at
1.665 (2) A˚ is comparable to the bonds of similar boron
nitrogen coordinated complexes.16
To establish the optimal catalytic load required to
achieve high enantioselectivity, the reduction of ace-
tophenone was studied using diﬀerent molar equivalents
of catalyst 1 with 0.7 M equiv of BH3ÆDMS complex in
THF at room temperature. As indicated in Figure 2,
10 mol % of catalyst 1 aﬀorded (R)-1-phenylethanol
with 99% ee. Moreover, higher enantioselectivities
(98% ee) were achieved with as low as 0.5 M % of cata-
lytic load, and even with 0.1 M % of catalyst 1, the enan-
tiomeric excess was high (89%).
Spiroborates 2 and 3 were also investigated for the
reduction of acetophenone obtaining (R)-1-phenyletha-
nol with excellent chemical yield and 98% and 96% ee,80
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Figure 2. Asymmetric reduction of acetophenone in the presence of
catalyst 1.respectively. In addition, catalyst 2 showed excellent
enantioselectivity even with 5 mol % loading (98% ee).
The reduction of representative arylalkyl and aliphatic
ketones was also investigated and the results are shown
in Table 1.17 In general, the optical active alcohols were
obtained in excellent chemical yields and outstanding
enantio-purity for ketones with bulky group
diﬀerentiation.
It was of interest to study the eﬀect of electronic and
steric factors in the reduction of halogenated aceto-
phenones. Moreover, their enantiopure alcohols are
very important intermediaries in organic synthesis.12
O
1 83 61 (R)
13
O
1 98 99 (R)
a 1 equiv ketone, 0.7 equiv BH3ÆDMS and 0.1 equiv catalyst in THF at
rt.
b Puriﬁed by ﬂash chromatography column or Kugelrohr distillation.
c Determined by 31P NMR of derivate with phosphonate (CDA).
d Determined by GC of alcohol on Chiral Column (CP-Chirasil-
DexCB).
e Determined by GC of acetyl derivative on Chiral Column.
f Determined by HPLC of acetyl derivative on Chiral Column (Chi-
ralpack ID).
Table 2. Reduction of representative halogenated aromatic ketones
with spiroborate with 0.1 equiv of catalyst 1
Entry Substratea Yieldb (%) eec (%)
1
O
Cl
98 99d (R)
2
O
Br
84 98e (R)
3
O
F
Cl
83 95e (S)
4
O
F
Cl
F
88 98 (S)
5 CF3
O
97 82 (S)
6 Cl
O
86 94 (R)
a 1 equiv ketone, 0.7 equiv BH3ÆDMS and 0.1 equiv catalyst in THF at
rt.
b Puriﬁed by ﬂash chromatography column or Kugelrohr distillation.
c Determined by 31P NMR of derivate with phosphonate (CDA).
dDetermined by GC of alcohol on Chiral Column (CP-Chirasil-
DexCB).
e Determined by GC of acetyl derivative on Chiral Column.
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DMS in the presence of 10 mol % of catalyst 1 providing
their corresponding alcohols with high enantio-
purity (94–99% ee), except for the highly reactive
2,2,2,-triﬂuoroacetophenone (82% ee, entry 5), as illus-
trated in Table 2.
In conclusion, a facile and eﬃcient method for the
reduction of aralkyl-, aliphatic- and halogenated aro-
matic ketones in the presence of up to 0.5 mol % cata-
lysts 1 with outstanding enantioselectivities has been
established. Catalyst 1 oﬀer an excellent alternative for
asymmetric reduction of ketones similar in enantioselec-
tivity to those reported for B-methyl oxazaborolidine
(CBS reagent).7Acknowledgements
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